» Articles » PMID: 37085023

Neurosteroid Enantiomers As Potentially Novel Neurotherapeutics

Overview
Date 2023 Apr 21
PMID 37085023
Authors
Affiliations
Soon will be listed here.
Abstract

Endogenous neurosteroids and synthetic neuroactive steroids (NAS) are important targets for therapeutic development in neuropsychiatric disorders. These steroids modulate major signaling systems in the brain and intracellular processes including inflammation, cellular stress and autophagy. In this review, we describe studies performed using unnatural enantiomers of key neurosteroids, which are physiochemically identical to their natural counterparts except for rotation of polarized light. These studies led to insights in how NAS interact with receptors, ion channels and intracellular sites of action. Certain effects of NAS show high enantioselectivity, consistent with actions in chiral environments and likely direct interactions with signaling proteins. Other effects show no enantioselectivity and even reverse enantioselectivity. The spectrum of effects of NAS enantiomers raises the possibility that these agents, once considered only as tools for preclinical studies, have therapeutic potential that complements and in some cases may exceed their natural counterparts. Here we review studies of NAS enantiomers from the perspective of their potential development as novel neurotherapeutics.

Citing Articles

Blood Metabolome Mediates the Effect of the Plasma Lipidome on the Risk of Atrial Fibrillation: A Mendelian Randomization Study.

Su Y, Ning Y, Jiang Z, Zhong G Clin Cardiol. 2025; 48(3):e70112.

PMID: 40051326 PMC: 11885885. DOI: 10.1002/clc.70112.


Effects of acute pro-inflammatory stimulation and 25-hydroxycholesterol on hippocampal plasticity and learning involve NLRP3 inflammasome and cellular stress responses.

Izumi Y, ODell K, Mennerick S, Zorumski C Sci Rep. 2025; 15(1):6149.

PMID: 39979396 PMC: 11842721. DOI: 10.1038/s41598-025-90149-2.


Stereospecific Properties and Intracellular Transport of Novel Intrinsically Fluorescent Neurosteroids.

Akkerman V, Reinholdt P, Schnoor-Madsen R, Lauritsen L, Bader J, Qian M ACS Chem Neurosci. 2024; 15(23):4322-4336.

PMID: 39574303 PMC: 11892034. DOI: 10.1021/acschemneuro.4c00571.


Reduced Levels of Neurosteroids in Cerebrospinal Fluid of Amyotrophic Lateral Sclerosis Patients.

Lucchi C, Simonini C, Rustichelli C, Avallone R, Zucchi E, Martinelli I Biomolecules. 2024; 14(9).

PMID: 39334843 PMC: 11430417. DOI: 10.3390/biom14091076.


5β-Dihydrosteroids: Formation and Properties.

Penning T, Covey D Int J Mol Sci. 2024; 25(16).

PMID: 39201544 PMC: 11354470. DOI: 10.3390/ijms25168857.


References
1.
Qian M, Krishnan K, Kudova E, Li P, Manion B, Taylor A . Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone. J Med Chem. 2013; 57(1):171-90. PMC: 3951241. DOI: 10.1021/jm401577c. View

2.
Bjorkhem I, Meaney S . Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol. 2004; 24(5):806-15. DOI: 10.1161/01.ATV.0000120374.59826.1b. View

3.
Wittmer L, Hu Y, Kalkbrenner M, Evers A, Zorumski C, Covey D . Enantioselectivity of steroid-induced gamma-aminobutyric acidA receptor modulation and anesthesia. Mol Pharmacol. 1996; 50(6):1581-6. View

4.
Kapras V, Vyklicky V, Budesinsky M, Cisarova I, Vyklicky L, Chodounska H . Total Synthesis of ent-Pregnanolone Sulfate and Its Biological Investigation at the NMDA Receptor. Org Lett. 2018; 20(4):946-949. DOI: 10.1021/acs.orglett.7b03838. View

5.
Meyer D, Carta M, Donald Partridge L, Covey D, Valenzuela C . Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. Possible role of metabotropic sigma1-like receptors. J Biol Chem. 2002; 277(32):28725-32. DOI: 10.1074/jbc.M202592200. View